Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis
Open accessThe DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.
Abstract
(R)-Roscovitine, a pharmacological inhibitor of kinases, is currently in phase II clinical trial as a drug candidate for the treatment of cancers, Cushing's disease and rheumatoid arthritis. We here review the data that support the investigation of (R)-roscovitine as a potential therapeutic agent for the treatment of cystic fibrosis (CF). (R)-Roscovitine displays four independent properties that may favorably combine against CF: (1) it partially protects F508del-CFTR from proteolytic degradation and favors its trafficking to the plasma membrane; (2) by increasing membrane targeting of the TRPC6 ion channel, it rescues acidification in phagolysosomes of CF alveolar macrophages (which show abnormally high pH) and consequently restores their bactericidal activity; (3) its effects on neutrophils (induction of apoptosis), eosinophils (inhibition of degranulation/induction of apoptosis) and lymphocytes (modification of the Th17/Treg balance in favor of the differentiation of anti-inflammatory lymphocytes and reduced production of various interleukins, notably IL-17A) contribute to the resolution of inflammation and restoration of innate immunity, and (4) roscovitine displays analgesic properties in animal pain models. The fact that (R)-roscovitine has undergone extensive preclinical safety/pharmacology studies, and phase I and II clinical trials in cancer patients, encourages its repurposing as a CF drug candidate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The capsaicin receptor: a heat-activated ion channel in the pain pathway
Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. (1997) · Nature · doi:10.1038/39807 · Cited by 9,107
Impaired nociception and pain sensation in mice lacking the capsaicin receptor
Caterina, M. J., Leffler, A., Malmberg, A. B., Martin, W. J., Trafton, J., Petersen-Zeitz, K. R., Koltzenburg, M., Basbaum, A. I., & Julius, D. (2000) · Science · doi:10.1126/science.288.5464.306 · Cited by 3,544
Novel cell death program leads to neutrophil extracellular traps
Fuchs, T. A., Abed, U., Goosmann, C., Hurwitz, R., Schulze, I., Wahn, V., Weinrauch, Y., Brinkmann, V., & Zychlinsky, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200606027 · Cited by 3,197
The Cloned Capsaicin Receptor Integrates Multiple Pain-Producing Stimuli
Tominaga, M., Caterina, M. J., Malmberg, A. B., Rosen, T. A., Gilbert, H., Skinner, K., Raumann, B. E., Basbaum, A. I., & Julius, D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80564-4 · Cited by 3,081
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
Papayannopoulos, V., Metzler, K. D., Hakkim, A., & Zychlinsky, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201006052 · Cited by 2,103
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia
Davis, J. B., Gray, J., Gunthorpe, M. J., Hatcher, J. P., Davey, P. T., Overend, P., Harries, M. H., Latcham, J., Clapham, C., Atkinson, K., et al. (2000) · Nature · doi:10.1038/35012076 · Cited by 1,760
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1409547 · Cited by 1,622
Plasticity of CD4+ T Cell Lineage Differentiation
Zhou, L., Chong, M. M. W., & Littman, D. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.001 · Cited by 1,551
Wang, Y., Li, M., Stadler, S., Correll, S., Li, P., Wang, D., Hayama, R., Leonelli, L., Han, H., Grigoryev, S. A., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200806072 · Cited by 1,521
Research works printed but not linked: 27
- 10.1159/000350215 · doi:10.1159/000350215
- 10.1021/ar0201198 · DOI
- 10.1097/01.ASN.0000124672.41036.F4 · doi:10.1097/01.asn.0000124672.41036.f4
- 10.1111/nyas.12001 · doi:10.1111/nyas.12001
- 10.1096/fj.03-0035fje · DOI
- 10.1158/1078-0432.CCR-08-1748 · doi:10.1158/1078-0432.ccr-08-1748
- 10.1530/REP-07-0069 · doi:10.1530/rep-07-0069
- 10.4161/cbt.4.1.1462 · doi:10.4161/cbt.4.1.1462
- 10.2174/156802611795589601 · doi:10.2174/156802611795589601
- 10.2174/1568026611313030008 · doi:10.2174/1568026611313030008
- 10.1111/bph.12723 · doi:10.1111/bph.12723
- 10.1042/BJ20021975 · DOI
- 10.2174/138920111793937943 · doi:10.2174/138920111793937943
- 10.1177/1947601910369817 · DOI
- 10.1016/j.jcf.2012.07.003 · DOI · Paper page
- 10.1159/000350215 · doi:10.1159/000350215
- 10.1136/thx.2008.096834 · doi:10.1136/thx.2008.096834
- 10.1159/000295791 · doi:10.1159/000295791
- 10.1136/thx.49.5.496 · doi:10.1136/thx.49.5.496
- 10.1111/imm.12416 · DOI
- 10.3109/08820139.2014.888447 · doi:10.3109/08820139.2014.888447
- 10.1371/journal.pone.0081154 · DOI
- 10.1097/MEG.0000000000000011 · doi:10.1097/meg.0000000000000011
- 10.1007/s10072-014-1713-9 · doi:10.1007/s10072-014-1713-9
- 10.1016/j.brainresbull.2014.04.008 · DOI
- 10.1111/j.1745-7254.2005.00007.x · DOI
- 10.2174/1574892810666150617112230 · doi:10.2174/1574892810666150617112230
Cited by
Items 401–432 of 432
Lentiviral Vectors for the Treatment and Prevention of Cystic Fibrosis Lung Disease
Marquez Loza, L. I., Yuen, E. C., & McCray, P. B. (2019) · Genes · doi:10.3390/genes10030218 · Cited by 59
Scozzi, D., Wang, X., Liao, F., Liu, Z., Zhu, J., Pugh, K., Ibrahim, M., Hsiao, H.-M., Miller, M. J., Yizhan, G., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15163 · Cited by 58
Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies
Tyrrell, J., & Callaghan, M. (2016) · Microbiology · doi:10.1099/mic.0.000220 · Cited by 56
ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration
Hirose, T., Cabrera-Socorro, A., Chitayat, D., Lemonnier, T., Féraud, O., Cifuentes-Diaz, C., Gervasi, N., Mombereau, C., Ghosh, T., Stoica, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci79990 · Cited by 55
Calcium and activity-dependent signaling in the developing cerebral cortex
Arjun McKinney, A., Petrova, R., & Panagiotakos, G. (2022) · Development · doi:10.1242/dev.198853 · Cited by 55
Caceres, S. M., Malcolm, K. C., Taylor-Cousar, J. L., Nichols, D. P., Saavedra, M. T., Bratton, D. L., Moskowitz, S. M., Burns, J. L., & Nick, J. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03514-14 · Cited by 50
Aging hampers neutrophil extracellular traps (NETs) efficacy
Sabbatini, M., Bona, E., Novello, G., Migliario, M., & Renò, F. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02201-0 · Cited by 51
Yarotskyy, V, & Elmslie, K. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707414 · Cited by 49
Phosphorylation Site Mutations Affect Herpes Simplex Virus Type 1 ICP0 Function
Davido, D. J., von Zagorski, W. F., Lane, W. S., & Schaffer, P. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1232-1243.2005 · Cited by 49
Apocynin and Nox2 regulate NF-κB by modifying thioredoxin-1 redox-state
Trevelin, S. C., dos Santos, C. X., Ferreira, R. G., de Sá Lima, L., Silva, R. L., Scavone, C., Curi, R., Alves-Filho, J. C., Cunha, T. M., Roxo-Júnior, P., et al. (2016) · Scientific Reports · doi:10.1038/srep34581 · Cited by 48
Mutation-specific downregulation of CFTR2 variants by gating potentiators
Avramescu, R. G., Kai, Y., Xu, H., Bidaud-Meynard, A., Schnúr, A., Frenkiel, S., Matouk, E., Veit, G., & Lukacs, G. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx367 · Cited by 43
Bavley, C. C., Fischer, D. K., Rizzo, B. K., & Rajadhyaksha, A. M. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2017.02.004 · Cited by 41
Role of piRNA biogenesis and its neuronal function in the development of neurodegenerative diseases
Sato, K., Takayama, K.-I., & Inoue, S. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1157818 · Cited by 41
Halogenation Activity of Mammalian Heme Peroxidases
Arnhold, J., & Malle, E. (2022) · Antioxidants · doi:10.3390/antiox11050890 · Cited by 40
Targeting Memory T Cells in Type 1 Diabetes
Ehlers, M. R., & Rigby, M. R. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0659-5 · Cited by 40
Morandini, L., Avery, D., Angeles, B., Winston, P., Martin, R. K., Donahue, H. J., & Olivares-Navarrete, R. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.05.016 · Cited by 40
Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders
Schadt, E. E., Buchanan, S., Brennand, K. J., & Merchant, K. M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00252 · Cited by 39
In vitro Methods for the Development and Analysis of Human Primary Airway Epithelia
Gianotti, A., Delpiano, L., & Caci, E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01176 · Cited by 38
Putman, M. S., Norris, A. W., Hull, R. L., Rickels, M. R., Sussel, L., Blackman, S. M., Chan, C. L., Ode, K. L., Daley, T., Stecenko, A. A., et al. (2023) · Diabetes Care · doi:10.2337/dc23-0380 · Cited by 35
Memory CD8(+) T Cells: Innate-Like Sensors and Orchestrators of Protection
Lauvau, G., Boutet, M., Williams, T. M., Chin, S. S., & Chorro, L. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.04.001 · Cited by 35
The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases
Gonçalves, S. M., Lagrou, K., Duarte-Oliveira, C., Maertens, J. A., Cunha, C., & Carvalho, A. (2017) · Virulence · doi:10.1080/21505594.2016.1257458 · Cited by 32
TCR-signaling events in cellular metabolism and specialization
Chisolm, D. A., & Weinmann, A. S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00292 · Cited by 26
BICD2 phosphorylation regulates dynein function and centrosome separation in G2 and M
Gallisà-Suñé, N., Sànchez-Fernàndez-de-Landa, P., Zimmermann, F., Serna, M., Regué, L., Paz, J., Llorca, O., Lüders, J., & Roig, J. (2023) · Nature Communications · doi:10.1038/s41467-023-38116-1 · Cited by 26
Variable cellular ivacaftor concentrations in people with cystic fibrosis on modulator therapy
Guimbellot, J. S., Ryan, K. J., Anderson, J. D., Liu, Z., Kersh, L., Esther, C. R., Rowe, S. M., & Acosta, E. P. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.01.011 · Cited by 24
Maccioni, L., Loriot, A., Dewulf, J., Bommer, G., Horsmans, Y., Lanthier, N., Leclercq, I., Schnabl, B., & Stärkel, P. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17177 · Cited by 23
Shimizu, M., Shibuya, H., & Tanaka, N. (2022) · Scientific Reports · doi:10.1038/s41598-022-06916-y · Cited by 18
Brunel, S. F., Willment, J. A., Brown, G. D., Devereux, G., & Warris, A. (2018) · ERJ Open Research · doi:10.1183/23120541.00068-2017 · Cited by 17
Arsenic and Tau Phosphorylation: A Mechanistic Review
Ariafar, S., Makhdoomi, S., & Mohammadi, M. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03634-y · Cited by 13
The Alzheimer’s Disease–Associated Protein BACE1 Modulates T Cell Activation and Th17 Function
Hernandez-Mir, G., Raphael, I., Revu, S., Poholek, C. H., Avery, L., Hawse, W. F., Kane, L. P., & McGeachy, M. J. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800363 · Cited by 14
Methods for Quantifying Neutrophil Extracellular Traps on Biomaterials
Fetz, A. E., King, W. E., Minden-Birkenmaier, B. A., & Bowlin, G. L. (2022) · Methods in Molecular Biology · doi:10.1007/978-1-0716-1811-0_38 · Cited by 7
Genome mining yields putative disease-associated ROMK variants with distinct defects
(2023) · doi:10.1371/journal.pgen.1011051 · Cited by 7
Holzinger, J. M., Toelge, M., Werner, M., Ederer, K. U., Siegmund, H. I., Peterhoff, D., Blaas, S. H., Gisch, N., Brochhausen, C., Gessner, A., et al. (2023) · eLife · doi:10.7554/elife.86369 · Cited by 4
Metadata
- Authors
- Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., Gueganton, L., Dorothée, G., Prochazkova, M., Hall, B., Kulkarni, A. B., Gray, R. D., Rossi, A. G., Witko-Sarsat, V., Norez, C., Becq, F., Ravel, D., Mottier, D., & Rault, G.
- Venue
- Journal of Innate Immunity
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 8
- Issue
- 4
- Pages
- 330-349
- ISSN
- 1662-811X (ISSN-L)
- 1662-8128
- OpenAlex
- W2301131921
- Cited by
- 4,992
- References
- 272
- FWCI
- 438.81
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.